James Kelly Ganjei

CIK: 0001767300

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)10 (55.6%)

Compensation grants

Other (G, F, J, C, D, …)8 (44.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INMB

Inmune Bio, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (18 total)

INMB
Inmune Bio, Inc.
Dec 1, 2025
Award(A)
Option (right to buy)
Direct
150K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Disposition(D)
Stock Option (right to buy)
Direct
108K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Award(A)
Stock Option (right to buy)
Direct
108K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Disposition(D)
Stock Option (right to buy)
Direct
108K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Award(A)
Stock Option (right to buy)
Direct
108K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Disposition(D)
Stock Option (right to buy)
Direct
16K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Award(A)
Stock Option (right to buy)
Direct
16K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Disposition(D)
Stock Option (right to buy)
Direct
19K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Award(A)
Stock Option (right to buy)
Direct
19K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Disposition(D)
Stock Option (right to buy)
Direct
35K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Award(A)
Stock Option (right to buy)
Direct
35K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Disposition(D)
Stock Option (right to buy)
Direct
35K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Award(A)
Stock Option (right to buy)
Direct
35K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Disposition(D)
Stock Option (right to buy)
Direct
32.5K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Award(A)
Stock Option (right to buy)
Direct
32.5K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Disposition(D)
Stock Option (right to buy)
Direct
12.5K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Award(A)
Stock Option (right to buy)
Direct
12.5K shares-
INMB
Inmune Bio, Inc.
Dec 5, 2024
Award(A)
Option (right to buy)
Direct
32.5K shares-

		Type	Shares	Price		Ownership
Dec 1, 2025	INMB Inmune Bio, Inc.	Award(A) Option (right to buy)	150,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Disposition(D) Stock Option (right to buy)	108,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Award(A) Stock Option (right to buy)	108,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Disposition(D) Stock Option (right to buy)	108,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Award(A) Stock Option (right to buy)	108,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Disposition(D) Stock Option (right to buy)	15,975	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Award(A) Stock Option (right to buy)	15,975	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Disposition(D) Stock Option (right to buy)	19,025	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Award(A) Stock Option (right to buy)	19,025	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Disposition(D) Stock Option (right to buy)	35,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Award(A) Stock Option (right to buy)	35,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Disposition(D) Stock Option (right to buy)	35,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Award(A) Stock Option (right to buy)	35,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Disposition(D) Stock Option (right to buy)	32,500	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Award(A) Stock Option (right to buy)	32,500	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Disposition(D) Stock Option (right to buy)	12,500	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Award(A) Stock Option (right to buy)	12,500	-	-	Direct
Dec 5, 2024	INMB Inmune Bio, Inc.	Award(A) Option (right to buy)	32,500	-	-	Direct

1-18 of 18 transactions

About Ganjei James Kelly

Ganjei James Kelly (SEC CIK 0001767300) files insider reports with the SEC as Director of Inmune Bio, Inc. (INMB).

Signal8 holds 3 ownership filings by Ganjei James Kelly, all Form 4s, filed between Dec 9, 2024 and Dec 2, 2025. Those filings report 18 transactions, from Dec 5, 2024 to Dec 1, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Ganjei James Kelly's filings is in BOCA RATON,, FL.

Recent filings by Ganjei James Kelly

Dec 1, 2025: Grant or award of INMB derivative securities (Form 4, code A).
Nov 18, 2025: Disposition to issuer transaction of INMB derivative securities (Form 4, code D).
Nov 18, 2025: Grant or award of INMB derivative securities (Form 4, code A).
Nov 18, 2025: Disposition to issuer transaction of INMB derivative securities (Form 4, code D).
Nov 18, 2025: Grant or award of INMB derivative securities (Form 4, code A).

Other insiders filing for Inmune Bio, Inc. (INMB)

Clark Ronnie Duane, Director
SAPIRSTEIN JAMES, Director
Juda Scott, Director
Lowdell Mark William, Chief Scientific Officer
Moss David J, Chief Executive Officer
Ellspermann Cory Randall, Interim CFO

How to read Form 4 transaction codes